Previous Issue - Issue 59
Issue 59 | 2025
- Foreword
- Strategy
- Manufacturing
- Information Technology
- Expert Corner
- Advertorials
- BioPharma Go to Digital Magazine
Issue 59
PREVIOUS ISSUE
Foreword
Reimagining the Pharmaceutical Industry through Scenario Planning
The pharmaceutical industry is at a pivotal juncture shaped by rapid technological breakthroughs changing regulatory
Strategy
The Future of the Pharmaceutical Industry
A scenario planning approach
The pharmaceutical industry is one of the most critical sectors in healthcare responsible for developing
The Middle East
Big opportunities for big pharma
The Middle Eastern pharmaceutical market is undergoing an unmatched transformation fuelled by robust economic
Manufacturing
Toxicological Approaches to Deal with Out-of-specification Impurities
The pharmaceutical industry is a pillar of hope for millions of people providing medications that alleviate
Information Technology
Humanising Artificial Intelligence In Biopharma and Healthcare
Using blockchain as information gatekeeper
The integration of artificial intelligence AI into biopharmaceutical and healthcare holds immense promise for
Adoption of Blockchain in the Pharmaceutical Supply Chain
Enhancing transparency and security
The pharmaceutical supply chain is inherently complex involving multiple stakeholders from raw material suppliers
Expert Corner
CDMOs
Choose your partner wisely!
Over the past decade the role of a contract development and manufacturing organisation CDMO in the biotech and pharma industries
Nanotechnology in Pharmaceutics and Drug Delivery Systems
Nucleic acid pharmaceuticals have proven their potential to successfully treat or prevent intractable diseases
Impact of AI (LLMs & SLMs) in Clinical Trials for Precision Medicine
In the realm of healthcare and oncology data sources primarily fall into two categories
Next Generation Drug Delivery
Advancing container closure systems for enhanced therapeutic performance
Advanced drug delivery technologies represent a convergence of innovative materials science
Diversity and Inclusion in Clinical trials
Historical disparities in clinical trial participation have significantly compromised the generalisability of drug safety
Advertorials
Enterprise Recipe Management
A faster time to market
The RD cycles NPDI new product development and introduction in the pharmaceutical industry are timeconsuming
BioPharma
Bharat, Bioeconomy and Biotechnology
Bharat known globally as India has emerged as a major player in science technology and healthcare
